Broker Recommendations
Berenberg lowers target price on NatWest
Analysts at Berenberg lowered their target price on banking group NatWest from 380. 0p to 360. 0p on Monday, stating "conservative guidance" had provided a floor.
BofA's Hartnett believes Fed's job 'very much unaccomplished'
BofA's investment strategies believed that the Federal Reserve's job was "very much unaccomplished".
Berenberg hikes target price on Standard Chartered
Analysts at Berenberg hiked their target price on consumer bank Standard Chartered from 750. 0p to 1,000. 0p on Friday, citing "increasingly evident" standalone strength.
Citi reiterates 'buy' on Centrica after results
Citi reiterated its ‘buy’ rating on Centrica on Friday following a "strong" set of results a day earlier and as it highlighted the potential for further cash return to shareholders after the announced second tranche of share buyback.
RBC Capital downgrades Direct Line, says risk/reward more balanced
RBC Capital Markets downgraded Direct Line on Friday to ‘sector perform’ from ‘outperform’ and slashed the price target to 190p from 260p, as it said the risk/reward of the shares is now more balanced.
Liberum sees 'selective value' in UK REITs, upgrades Hammerson
Analysts at Liberum sounded a bullish note on the outlook for the the UK Real Estate Investment Trust space, telling clients that share prices now reflected the expected declines in direct property values.
Berenberg raises target price on Shell
Analysts at Berenberg raised their target price on energy giant Shell from 2,900. 0p to 3,000. 0p on Thursday, stating the group's free cash flow generation remained "attractive".
Morgan Stanley starts RS Group at 'equalweight'
Morgan Stanley initiated coverage of industrial and electric components distributor RS Group on Thursday with an ‘equalweight’ rating and 950p price target as is pointed to a strong track record of organic growth, improving margins and return on invested capital.
Peel Hunt stays at 'buy' on Hargreaves Lansdown after 1H beat
Analysts at Peel Hunt reiterated their 'buy' recommendation for shares of Hargreaves Lansdown following the firm's full-year numbers, telling clients the results were "well ahead of expectations".
Berenberg hikes Pets at Home price target
Berenberg lifted its price target on Pets at Home on Wednesday to 430p from 370p and reiterated its ‘buy’ recommendation as it said the upgrade cycle wasn’t over.
Investec downgrades Rathbones on valuation grounds
Investec downgraded wealth manager Rathbones to ‘hold’ from ‘buy’ on Tuesday after the shares outperformed the sector by over 30% in the past 12 months, making the risk/reward dynamic less attractive.
Investor pessimism hits 12-month low in February, BofA says
The so-called 'pain trade' in risk assets was still up because investors around the world continued to exhibit caution, the results of BofA's monthly fund manager survey found.
JPMorgan lifts Drax price target, expects strong 2023 guidance
JPMorgan Cazenove lifted its price target on Drax on Tuesday to 900p from 850p and said it remains on its "Positive Catalyst Watch" into results later this month.
Berenberg initiates coverage on Ashtead Technology at 'buy'
Analysts at Berenberg initiated coverage on subsea equipment and solutions group Ashtead Technology at 'buy' on Thursday, branding the firm "a market leader in a thriving sector".
Deutsche Bank upgrades EasyJet on 'dramatic' improvement in UK economic outlook
Analysts at Deutsche Bank upgraded their recommendation for shares of Easyjet on the back of what they said had been a "dramatic" improvement in the outlook for the UK economy in 2023.
RBC Capital Markets slightly lowers target price on Impact Healthcare
Analysts at RBC Capital Markets slightly lowered their target price on real estate investment trust Impact Healthcare from 125. 0p to 120. 0p on Tuesday as it reduced its earnings forecasts following the trust's recent trading update.
Berenberg raises target price on Lancashire Holdings
Analysts at Berenberg raised their target price on insurance firm Lancashire Holdings from 645. 0p to 770. 0p on Monday, stating the group was entering 2023 from "a position of strength".
RBC Capital downgrades Pennon, Severn Trent
RBC Capital Markets downgraded Pennon and Severn Trent on Monday.
HSBC downgrades Abrdn, cautious on near-term prospects for wealth managers
HSBC downgraded Abrdn on Friday to ‘reduce’ from ‘hold’ as it took a look at UK wealth managers.
Berenberg raises target price on GSK
Analysts at Berenberg raised their target price on drugmaker GSK from £15. 80 each to £17. 30 on Friday, citing "steady progress".